CHARLES WHITING: Open Payments
NPI 1992867956 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 143 payments from 19 companies in 2025. Trend: 2023 $1,009 · 2024 $1,459 · 2025 $2,006
Food & beverage: $1,975Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $452 |
| Janssen Biotech, Inc. | 30 | $344 |
| Ardelyx, Inc. | 26 | $251 |
| Aimmune Therapeutics, Inc. | 18 | $137 |
| Phathom Pharmaceuticals, Inc. | 7 | $134 |
| Lilly USA, LLC | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Intercept Pharmaceuticals, Inc. | 4 | $79 |
| PFIZER INC. | 2 | $50 |
Products named: TREMFYA, IBSRELA, RINVOQ, VOQUEZNA, OMVOH, ENTYVIO, DUPIXENT, ZENPEP.
Industry payments across SC — which companies pay providers there.
